ANCA glomerulonephritis and vasculitis: A Chapel Hill perspective

Keyphrases

• Remission 100%
• Serum Creatinine 100%
• Pulmonary Hemorrhage 100%
• Chapel Hill 100%
• ANCA-associated Vasculitis 100%
• Large Vessel Vasculitis 100%
• ANCA Glomerulonephritis 100%
• Lung 50%
• Improved Outcomes 50%
• Clinical Features 50%
• Clinical Manifestations 50%
• Kidney 50%
• End-stage Renal Disease 50%
• Capillary 50%
• Autoantibodies 50%
• Plasmapheresis 50%
• Pathological Features 50%
• Renal Transplantation 50%
• Myeloperoxidase 50%
• Upper Respiratory Tract 50%
• Immunoglobulin 50%
• Renal Manifestations 50%
• Glomerulonephritis 50%
• Glomerulosclerosis 50%
• Small Arteries 50%
• Venules 50%
• Long-term Prognosis 50%
• Prognostic Marker 50%
• Alkylating Agents 50%
• Immunofluorescence Microscopy 50%
• Glomerular Lesions 50%
• Wegener's Granulomatosis 50%
• High-dose Corticosteroids 50%
• Rapid Diagnosis 50%
• Pauci-immune Glomerulonephritis 50%
• Rapidly Progressive Glomerulonephritis 50%
• Churg-Strauss Syndrome 50%
• High-dose Cyclophosphamide 50%
• Crescent Formation 50%
• Necrotizing Glomerulonephritis 50%
• Microscopic Polyangiitis 50%
• Pathogenic Features 50%
• MPO-ANCA 50%
• Proteinase 3 (PR3)-ANCA 50%

Medicine and Dentistry

• Vasculitis 100%
• Glomerulonephritis 100%
• Creatinine 50%
• Pulmonary Hemorrhage 50%
• Small Vessel Vasculitis 50%
• Lung 25%
• Immunoglobulin 25%
• Drug Megadose 25%
• Clinical Feature 25%
• Kidney Transplantation 25%
• Cyclophosphamide 25%
• Capillary 25%
• End Stage Renal Disease 25%
• Upper Respiratory Tract 25%
• Myeloperoxidase 25%
• Venule 25%
• Granulomatosis with Polyangiitis 25%
• Alkylating Antineoplastic Agent 25%
• Arteriole 25%
• Immunofluorescence Microscopy 25%
• Rapidly Progressive Glomerulonephritis 25%
• Churg-Strauss Syndrome 25%
• Glomerulosclerosis 25%
• Plasmapheresis 25%
• Microscopic Polyangiitis 25%
• ANCA Associated Vasculitis 25%
• Pauci-Immune 25%
• Autoantibodies 25%
• Myeloblastin 25%
• Proteans 25%

Pharmacology, Toxicology and Pharmaceutical Science

• Glomerulonephritis 100%
• Vasculitis 100%
• Remission 50%
• Creatinine 50%
• Lung Hemorrhage 50%
• Small Vessel Vasculitis 50%
• Respiratory Tract 25%
• Immunoglobulin 25%
• Cyclophosphamide 25%
• End Stage Renal Disease 25%
• Alkylating Agent 25%
• Wegener Granulomatosis 25%
• Clinical Feature 25%
• ANCA Associated Vasculitis 25%
• Microscopic Polyangiitis 25%
• Churg Strauss Syndrome 25%
• Glomerulosclerosis 25%
• Autoantibodies 25%
• Myeloperoxidase 25%
• Myeloblastin 25%
• Rapidly Progressive Glomerulonephritis 25%